Basal cell carcinoma (BCC) is the most common cancer in the world and has a rising incidence....
Leggi tuttoDiagnosing clinically unclear basal cell carcinomas (BCCs) can be challenging....
Leggi tuttoBasal cell carcinoma (BCC) is the most common cancer in the world and has a rising incidence....
Leggi tuttoStudio osservazionale retrospettivo e prospettico sui pazienti affetti da carcinoma basocellulare avanzato...
Leggi tuttoBasal cell carcinoma can simulate melanoma and specific dermoscopic criteria have not yet been defined in a large cohort...
Leggi tuttoBasosquamous carcinoma (BSC) is a relatively rare type of neoplasm originating from basal cell carcinoma with features of squamous differentiation....
Leggi tuttoHistopathological classification of basal cell carcinoma (BCC) has important prognostic and therapeutic implications, but reproducibility of BCC subtyping among dermatopathologists is poor....
Leggi tuttoNo simple staging system has emerged for basal cell carcinomas (BCCs)...
Leggi tuttoNo simple classification system has emerged for 'advanced basal cell carcinomas', and more generally for all difficult-to-treat BCCs...
Leggi tuttoInfiltrative basal cell carcinoma (BCC) has a higher risk for post-surgical recurrence as compared to the most common low-aggressive superficial and nodular BCC....
Leggi tuttoIs exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?...
Leggi tuttoIdentifying Challenges and Practical Considerations for Successful Application...
Leggi tuttoPhotodynamic Therapy (PDT) with methyl-aminolevulinate (MAL-PDT) is being used for the treatment of Basal Cell Carcinoma (BCC), although resistant cells may appear....
Leggi tuttopatient‐reported outcomes from the MIKIE study...
Leggi tuttoThe incidence of basal cell carcinoma (BCC) is higher among men than women....
Leggi tuttoBasal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research ...
Leggi tuttoOrgan transplant recipients (OTR) have a higher risk of developing cutaneous squamous cell carcinoma (cSCC) compared to the immunocompetent population. Immunosuppression is often stated as a risk factor for metastasis. However, evidenc...
Leggi tuttoReflectance confocal microscopy (RCM)-based skin cancer diagnosis requires proficiency....
Leggi tuttoMerkel cell carcinoma (MCC) is a rare, aggressive malignancy, with high rates of recurrence and metastasis....
Leggi tuttoRisultati da 1 a 20 di 34